Patent · US Active

Crispr enzymes and systems

US11781172B2 · kind B2 · utility

5Cited by
9References
35Claims
0Family size

Assignees

Inventors

Key dates

Filing dateApr 30, 2019
Grant dateOct 10, 2023
Priority date
Expiry dateFeb 27, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/80
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention provides for systems, methods, and compositions for targeting nucleic acids. In particular, the invention provides non-naturally occurring or engineered DNA-targeting systems comprising a novel DNA-targeting CRISPR effector protein and at least one targeting nucleic acid component like a guide RNA. Methods for making and using and uses of such systems, methods, and compositions and products from such methods and uses are also disclosed and claimed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.